Close Menu

NEW YORK ─ Beckman Coulter said on Thursday that it was awarded funding by the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) for a multicenter clinical trial to validate its monocyte distribution width  (MDW) hematology biomarker for the rapid detection of multisystem inflammatory syndrome in children (MIS-C).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.